Bin Li just filed a "Statement of acquisition of beneficial ownership", which is also known as a 13D. In the filing, it appears as though Bin Li claims to own 3,362,000 shares. This represents 17.60% of Biocept.
Please note that typos are common in SEC filings. Please verify the information reported above before acting on it.
To receive a free e-mail notification whenever Biocept makes a similar move, sign up!